Amp Capital Investors LTD Biomarin Pharmaceutical Inc Transaction History

Amp Capital Investors LTD

$0
Q4 2022

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $3.01 Million - $3.84 Million	-42,020 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $387,084 - $442,478	-5,177 Reduced 10.97%	42,020 $3.25 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $35,571 - $43,168	-476 Reduced 1.0%	47,197 $3.56 Million
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $1.98 Million - $2.46 Million	-27,286 Reduced 36.4%	47,673 $4.15 Million
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $2.12 Million - $3.86 Million	29,448 Added 64.71%	74,959 $5.7 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $35,558 - $55,526	447 Added 0.99%	45,511 $5.56 Million
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $5,638 - $7,651	79 Added 0.18%	45,064 $3.72 Million
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $87,620 - $110,643	-1,300 Reduced 2.81%	44,985 $3.07 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $98,935 - $115,878	-1,175 Reduced 2.48%	46,285 $4.06 Million
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $6,972 - $9,228	-87 Reduced 0.18%	47,460 $3.97 Million
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $5.6 Million - $6.3 Million	-59,591 Reduced 55.62%	47,547 $4.66 Million
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $1.16 Million - $1.51 Million	-15,202 Reduced 12.43%	107,138 $10.1 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $303,301 - $361,720	-3,905 Reduced 3.09%	122,340 $9.74 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $215,225 - $253,521	-2,665 Reduced 2.07%	126,245 $11.3 Million
Q3 2017 Nov 14, 2017	SELL	$80.6 - $94.95 $100,508 - $118,402	-1,247 Reduced 0.96%	128,910 $12 Million
Q2 2017 Aug 14, 2017	BUY	N/A	130,157	130,157 $11.7 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Account